Novel human monoclonal antibodies specific to the alternatively spliced domain D of Tenascin C efficiently target tumors in vivo

• Ngā kaituhi matua: Lisa Nadal (Author), Riccardo Corbellari (Author), Alessandra Villa (Author), Tobias Weiss (Author), Michael Weller (Author), Dario Neri (Author), Roberto De Luca (Author)
• Hōputu: Pukapuka
• I whakaputaina: Taylor & Francis Group, 2020-01-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Antibody-based delivery of bioactive molecules represents a promising strategy for the improvement of cancer immunotherapy. Here, we describe the generation and characterization of R6N, a novel fully human antibody specific to the alternatively spliced domain D of Tenascin C, which is highly express...